Fiala

Peptide library › Bone health

Abaloparatide

Also known as Tymlos, Eladynos

FDA-approved drugBone health

Daily bone-building injection for osteoporosis in people at high risk of fractures.

What people use it for

What Abaloparatide does in the body

Mimics PTHrP, a relative of parathyroid hormone. Given in short daily pulses, it stimulates bone-building cells more than bone-removing cells, so bone density rises.

Strength of evidence

Strong: the ACTIVE trial cut new spine fractures by about 86% versus placebo.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2017 for women and in 2022 for men. Prescription only.

How it's taken

Route: Injection under the skin, once daily

How long it lasts (half-life): About 1.7 hours

Storage

Refrigerated before first use; then at room temperature for up to 30 days.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Abaloparatide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Abaloparatide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Bone health